1.Clinical Evaluation on Serial Changes of Serum Immunoglobulin E in Patients with Acute Myocardial Infarction.
Min Ki LEE ; Jung Yoo LEE ; Dong Il LEE ; Yeong Woo SHIN ; Yeong Kee SHIN
Korean Circulation Journal 1990;20(2):204-210
Serial changes of serum IgE, IgG, eosinophils were observed in 25 patients with acute myocaridial infarction and 20 ischemic heart disease without evidence of acute myocardial infarction and evaluated in terms of several parameters and its clinical significance. The results observed were as follows : 1) Serum IgE levels were propgressively elevated from the first hospital day(259+/-3IU/ml) up to peak level of the fifth hospital day(415+/-2IU/ml) and progressively lowered and returned to almost same level as the first hospital day on the twenty first hospital day. On the other hand control group showed significantly lower IgE levels throughout all hospital day and also did not showed serial change. 2) In the patient group with the initial serum IgE level above 200IU/m; showed significantly lower level of serum SGOT, CPK level than the group of below 200IU/ml group. This suggests the initial serum IgE level might have some correlation of the extent of myocardial necrosis. 3) In patients of acute myocardial infarction, ejection fraction was checked at discharge. Initial serum IgE level above 200IU/ml group showed significantly higher ejection fraction than below 200IU/ml group(59.4+/-13.5% vs 38.4+/-13.7%). 4) Serum IgE was checked concomittantly with serum IgE. It showed slightly decreasing tendency at third hospital day but not statistically significant. Eosinophil changed similar pattern as serum IgE but it was also not statistically significant. In conclusion, serial checking of serum IgE level in patient of acute myocardial infarction may give some help in prediction the clinical course and prognosis.
Aspartate Aminotransferases
;
Eosinophils
;
Hand
;
Humans
;
Immunoglobulin E*
;
Immunoglobulin G
;
Immunoglobulins*
;
Infarction
;
Myocardial Infarction*
;
Myocardial Ischemia
;
Necrosis
;
Prognosis
2.The Expression of Interleukin-6 in Chronic CCl4-induced Hepatotoxicity in Ethanol-fed Rabbits.
Sung Sook KIM ; Yeong Ju WOO ; Eun Hee HA ; Hee Jung SOHN ; Inpyoi CHOI
Korean Journal of Occupational and Environmental Medicine 1997;9(3):508-516
No abstract available.
Interleukin-6*
;
Rabbits*
3.Clinicopathologic Features and HBsAg and HBeAg Expressions in Hepatitis B Virus-associated Glomerulopathy.
Hye Kyoung YOON ; Woo Yeong CHUNG ; Soo Jin JUNG ; Yong Hoon KIM ; Su Yung KIM
Journal of the Korean Society of Pediatric Nephrology 1998;2(1):50-59
Morphometry of nuclei of the benign and malignant prostatic lesions was performed to study the relationship between nuclear size and shape and the prognosis of prostatic adenocarcinoma. Fifty one cases of prostatic adenocarcinoma and 13 cases of benign prostatic hyperplasia were included to evaluate area, perimeter, Dmax, Dmin, and 5 form factors of the nuclei by image analyzer (Zeiss Ibas 2000) using hematoxylin-eosin stained slides. All analytic factors of nuclear size and shape were significantly different between benign lesions and adenocarcinomas. Increased nuclear size was associated with nu- clear irregularity, presence of metastasis, advanced clinical stage, and high Gleason's grade and score of prostatic adenocarcinoma. On Kaplan-Meier method, survival was decreased with older age, no hormonal treatment, stage D, high Gleason's grade and stage as well as with larger size and irregular shape of the nuclei. In conclusion, morphometry of nuclei of the prostate can be a helpful tool to differentiate between benign and malignant lesions. Nuclear morphology is thought to be associated with prognosis of prostatic adenocarcinoma.
Adenocarcinoma
;
Breast
;
Fibroadenoma
;
Hepatitis B e Antigens*
;
Hepatitis B Surface Antigens*
;
Hepatitis B*
;
Hepatitis*
;
Neoplasm Metastasis
;
Prognosis
;
Prostate
;
Prostatic Hyperplasia
4.Effect of Speed of Injection on Vital Signs, Dose Requirement and Induction Time for Induction of Anesthesia using Propofol.
Jung Hwa YANG ; Seung Joon LEE ; Ho Yeong KIL ; Sung Woo LEE ; Young Joon YOON
Korean Journal of Anesthesiology 1997;33(2):262-266
BACKGROUND: Induction of anesthesia with propofol commonly associated with reduction in systemic arterial pressure, especially in elderly and high risk patients. This reduction is influenced by the dose and rate of propofol injection. The aim of this study was to examine the effect of different injection rate of propofol on vital signs, dose requirement and induction time during induction period. METHODS: Unpremedicated one hundred and twenty ASA physical status I and II patients aged 20~60 years scheduled for elective surgery were randomly allocated into one of four (150, 300, 600, 1200 ml/hr) groups according to speed of injection of propofol during induction period. Loss of verbal contact was taken as the end-point of induction. Vital signs, SpO2, dose requirement of propofol and induction time were checked. RESULTS: As the injection rate of propofol became slower, there were significant reduction in induction dose and increase in induction time (p<0.05). For example, induction dose and time were 1.82 mg/kg, 223 +/- 58 sec in 150 ml/hr group and 3.14 mg/kg, 50 +/- 11 sec in 1200 ml/hr group, respectively. Also, decrease in systolic and diastolic pressure were less marked at lower injection rates. CONCLUSIONS: Slower injection of propofol produces less vital sign changes and dose requirement for the induction of anesthesia.
Aged
;
Anesthesia*
;
Arterial Pressure
;
Blood Pressure
;
Humans
;
Propofol*
;
Vital Signs*
5.Successful desensitization for treatment of an exfoliative dermatitis to allopurinol.
Jung Won PARK ; Chein Soo HONG ; Yeong Yeon YUN ; Cheol Woo KIM ; Jung Sun KIM ; Won Chung JUNG ; Jung Yeop PARK ; Young Jun CHO ; Ae Jung HUH
Journal of Asthma, Allergy and Clinical Immunology 1999;19(6):980-984
Allopurinol is widely used for chronic tophaceous gout as a uric acid lowering agent. Hypersensitivity to allopurinol occurrs in about 10% of patients, which limits the usage of allopurinol. The successful oral and intravenous desensitization of allopurinol has been reported worldwide since 1976. We recently experienced a 51-year-old male patient with gouty arthritis and hyperuricemia, who had previously experienced skin rash after allopurinol treatment. When allopurinol was retried, erythematous and foliative skin rash developed on entire body. Because allopurinol was essential in controlling hyperuricemia, the oral desensitization of allopurinol was tried. We report successful rapid oral allopurinol desensitization in the patient with chronic tophaceous gout, who exhibited exfoliative dermatitis as allopurinol hypersensitivity.
Allopurinol*
;
Arthritis, Gouty
;
Dermatitis, Exfoliative*
;
Exanthema
;
Gout
;
Humans
;
Hypersensitivity
;
Hyperuricemia
;
Male
;
Middle Aged
;
Uric Acid
6.IKKγ Facilitates the Activation of NF-κB by Hepatitis C Virus Core Protein.
Bo Yeong KANG ; So Yeong LEE ; Jin Ik KIM ; Hye Jung CHOI ; Woo Hong JOO ; Dong Wan KIM
Journal of Bacteriology and Virology 2018;48(3):93-101
Hepatitis C virus (HCV) is a major cause of chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. HCV core protein has been shown to modulate various cellular signaling pathways including the nuclear factor κB (NF-κB) pathway which is associated with inflammation, cell proliferation and apoptosis. However, there have been conflicting reports about the effect of HCV core protein on NF-κB pathway, and the mechanism by which the core protein affects NF-κB activity remains nuclear. In this study, the functional interaction of HCV core protein and IκB kinase γ (IKKγ) was investigated using the expression plasmids of core and the components of IKK complex. The data revealed that HCV core protein activates NF-κB. Also, HCV core protein up-regulated the phosphorylation and degradation of IκBα. The activating effect of HCV core protein on NF-κB was synergistically elevated by IKKγ. It was noticed that the N-terminal IKKβ binding site, C-terminal leucine zipper, and zinc finger domains of IKKγ are not necessary for its synergistic effect. HCV core protein and IKKγ appeared to activate NF-κB by up-regulating the IKKβ activity resulting in the degradation of IκBα. As expected, HCV core protein induced the expression of NF-κB-targeted pro-inflammatory genes such as iNOS, IL-1β and IL-6 in the transcription level. These results suggest that HCV core protein induces NF-κB through the interaction with IKKγ and may play a critical role in the development of inflammation and related liver diseases.
Apoptosis
;
Binding Sites
;
Carcinoma, Hepatocellular
;
Cell Proliferation
;
Hepacivirus*
;
Hepatitis C*
;
Hepatitis*
;
Hepatitis, Chronic
;
Inflammation
;
Interleukin-6
;
Leucine Zippers
;
Liver Cirrhosis
;
Liver Diseases
;
Phosphorylation
;
Phosphotransferases
;
Plasmids
;
Zinc Fingers
7.Pseudomyxoma Peritonei A case of long term survival after operation.
Yeong Ho JUNG ; Woo Chan PARK ; Seung Taek OH ; Seung Jin YOO ; Se Kyung KIM ; In Chul KIM
Journal of the Korean Society of Coloproctology 1998;14(3):667-674
Pseudomyxoma peritonei may result from implantation of benign or malignant tumor in peritoneal cavity and is filled with gelatinous material (termed "Jelly Belly") in abdominal cavity. Its origin is usually an appendiceal or ovarian mucinous adenoma or cystadenocarcinoma, but other primary origin such as uterus, intestine, pancreas and stomach umor have been reported. Generally, pseudomyxoma peritonei is slowly progressive and has low grade malignant potential. This report presents a unusual long term survival after evacuation of 15,000 cc of gelatinous material from abdominal cavity which was the low grade mucinous adenocarcinoma and a review of the current literature, management and new its concept. The origin of pseudomyxoma peritonei of this case was most likely from appendiceal mvcinous adenocarcinoma.
Abdominal Cavity
;
Adenocarcinoma
;
Adenocarcinoma, Mucinous
;
Adenoma
;
Cystadenocarcinoma
;
Gelatin
;
Intestines
;
Mucins
;
Pancreas
;
Peritoneal Cavity
;
Pseudomyxoma Peritonei*
;
Stomach
;
Uterus
8.The Factors Affecting Accurate Quantitaion of Proteinuria Using Spot Urine Protein/Creatinine Ratio in Children.
Jimi JUNG ; Eunji KWON ; Woo Yeong CHUNG
Journal of the Korean Society of Pediatric Nephrology 2008;12(2):150-156
PURPOSE: Many results have reported a correlation between the spot urine protein/creatinine ratio(P/C ratio) and 24-hour urinary protein(24UP) amount. This study was designed to evaluated correlation between 24UP amounts and P/C ratio in children and to find the factors that affect this correlation. METHODS: 210 patients who visited the Department of Pediatrics in Busan Paik Hospital from september 2003 to december 2007 were included in this study. All the patients were divided into I, II, III/A, B, C group[I:24UP(mg/m2/day)]<100, II: 100< or =24UP<1,000, III: 24UP> or =1,000, A: Cr excretion(mg/kg)<15, B: 15< or =Cr excretion<25, C: Cr excretion> or =25)]. Pearson correlation analysis was performed between 24UP and P/C ratio to evaluate the relationship. We defined fractional difference between 24UP and P/C ratio, and then performed multiple regression analysis. RESULTS: There was a strong positive linear correlation between 24UP and P/C ratio in all patients, and the correlation was also good in each group. The factors affecting accurate quantitation of proteinuria using spot urine P/C ratio was creatinine excretion. CONCLUSION: Spot urine P/C ratio is a useful test to predict proteinuria roughly. Therefore, we expect that urine P/C ratio can be used as parameter instead of 24UP, if we set cutoff value of P/C ratio considered to creatinine excretion according to age and sex in large pediatric population.
Child
;
Creatinine
;
Humans
;
Pediatrics
;
Proteinuria
9.One Year result of Dermatophagoides farinae antigen - speciffic autologous antibody complex immunotherapy in respiratory allergic patients sensitized to house dust mite.
Jung Won PARK ; Chein Soo HONG ; Yeong Yeon YUN ; Si Hwan KO ; Cheol Woo KIM ; Kyung Sup KIM
Journal of Asthma, Allergy and Clinical Immunology 1999;19(4):566-575
BACKGROUND: Although good clinical effects have been reported, immunotherapy with house dust mite ( HDM ) antigen - autologous specific antibody complex ( IC - IT ) is not yet accepted as an effective immunomodulating tool in HDM allergic diseases. We aimed to prove the clinical effect of IC - IT in HDM sensitized respiratory allergic subjects. Method : Six HDM sensitized respiratory allergic subjects were enrolled. Autologous D. farinae specific IgG was purified with DEAE ion exchange and affinity chromatography. After one year of IC - IT treatment the clinical effects were analyzed with symptom scores, methacholine PC20, ELISA assay of D. farinae specific antibodies and intradermal skin reactivity. Result : The rhinitis symptom score significantly improved after a one - year administration of IC - IT ( 1.23 +/- 0.30 vs. 0.37 +/- 0.15, p< 0.05), but no significant differences were found in asthma symptom score, intradermal skin reactivity to D. farinae and ELISA optic absorbances of D. farinae specific IgE, IgG, and IgG subclasses. Methacholine PC20 values improved in all 6 patients who were administered with IC - IT ( 0.35 vs. 1.66 mg/ml, p< 0.05 ). CONCLUSION: IC - IT may be efficient for management of HDM atopic asthma. Further studies are needed before clinical application of IC - IT in house dust mite atopic subjects.
Antibodies
;
Asthma
;
Chromatography, Affinity
;
Dermatophagoides farinae*
;
Dust*
;
Enzyme-Linked Immunosorbent Assay
;
Humans
;
Immunoglobulin E
;
Immunoglobulin G
;
Immunotherapy*
;
Ion Exchange
;
Methacholine Chloride
;
Pyroglyphidae*
;
Rhinitis
;
Skin
10.Angiotensinogen M235T Polymorphism in Children with Henoch-Schonlein Purpura Nephritis.
Chang Woo HA ; Hee Jung JOO ; Ji Kyoung PARK ; Woo Yeong CHUNG
Journal of the Korean Society of Pediatric Nephrology 2004;8(1):10-17
PURPOSE: Henoch-Schonlein purpura(HSP) nephritis has a variable range of prevalence from 25 to 50% among HSP patients and is a common cause of chronic glomerulonephritis in children. In our study, we evaluated the distribution and the association of the angiotensinogen(AGT) M235T polymorphism with the clinical manifestations, particularly proteinuria in children with HSP with or without nephritis. METHODS: The AGT M235T polymorphism was determined in children with HSP nephritis (n=33) or HSP without nephritis(n=28) who had been diagnosed at Busan Paik hospital from January 1996 to June 2001. The M235T polymorphism of the AGT gene was determined by PCR amplification of the genomic DNA. RESULTS: The M235T polymorphism of AGT gene frequency was MM:75%, MT:25%, TT:0% in HSP and MM:64%, MT:36%, TT:0% in HSP nephritis, there was no significant differences in the genotype and allele frequencies between the two groups. No significant differences in clinical manifestations at onset and last follow-up were seen between the two genotypes. When statistical analysis was done according to the presence of the M allele, the amount of 24-hour urinary protein excretion and the incidence of moderate to heavy proteinuria(>500 mg/m2/day) at onset and at last follow-up were higher in the MT genotype than in those of in the MM genotype but these difference were not statistically significant. CONCLUSION: We suggest a lack of association between M235T polymorphism of the AGT gene and clinical manifestations in children with HSP nephritis. However, further follow-up studies based on sufficient number of patients and long term follow up periods are necessary to confirm the role of M235T polymorphism of AGT gene in children with HSP nephritis.
Alleles
;
Angiotensinogen*
;
Busan
;
Child*
;
DNA
;
Follow-Up Studies
;
Gene Frequency
;
Genotype
;
Glomerulonephritis
;
Humans
;
Incidence
;
Nephritis*
;
Polymerase Chain Reaction
;
Prevalence
;
Proteinuria
;
Purpura, Schoenlein-Henoch*